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http://dx.doi.org/10.1016/j.stemcr.2016.05.008SUMMARYNonsense-mediated RNA decay (NMD) is a highly conserved pathway that selectively degrades specific subsets of RNA transcripts. Here,
we provide evidence that NMD regulates early human developmental cell fate.We found that NMD factors tend to be expressed at higher
levels in human pluripotent cells than in differentiated cells, raising the possibility that NMD must be downregulated to permit differ-
entiation. Loss- and gain-of-function experiments in human embryonic stem cells (hESCs) demonstrated that, indeed, NMD downregu-
lation is essential for efficient generation of definitive endoderm. RNA-seq analysis identifiedNMD target transcripts inducedwhenNMD
is suppressed in hESCs, including many encoding signaling components. This led us to test the role of TGF-b and BMP signaling, which
we found NMD acts through to influence definitive endoderm versus mesoderm fate. Our results suggest that selective RNA decay is crit-
ical for specifying the developmental fate of specific human embryonic cell lineages.INTRODUCTION
Developmental processes depend on highly orchestrated
shifts in the levels of specific mRNAs. While regulation of
the synthesis of mRNAs (transcription) has traditionally
been the focus of attention, increasing evidence suggests
that developmentally regulated alterations in the rate of
decay of specific transcripts also influences developmental
decisions (Hwang and Maquat, 2011). The best-studied
RNA degradation pathway is nonsense-mediated RNA
decay (NMD). While originally identified as a quality con-
trol mechanism that rapidly degrades aberrant transcripts
derived frommutant genes, NMD was subsequently found
to also degrademany normal transcripts (Peccarelli and Ke-
baara, 2014). Between3% and 20% of the transcriptomes
of eukaryotic organisms ranging from yeast to man are
regulated (directly or indirectly) by NMD (Peccarelli and
Kebaara, 2014). The specific transcripts targeted by NMD
are those that harbor a stop codon in a ‘‘premature’’
context, as this leads to the formation of a complex of
NMD proteins that subsequently recruits RNA decay fac-
tors (Schoenberg and Maquat, 2012).
The discovery that NMD regulates normal gene expres-
sion raised the possibility that NMD can influence normal
biological events (Hwang and Maquat, 2011). By modu-
lating the magnitude of NMD, batteries of transcripts can
be stabilized or destabilized to achieve specific biological
outcomes. Indeed, NMD has been found to be a highly
regulated pathway, and mounting evidence supports the
possibility that NMD is critical for many biological events,
with loss of NMD resulting in developmental defects
(Huang and Wilkinson, 2012; Hwang and Maquat, 2011;844 Stem Cell Reports j Vol. 6 j 844–857 j June 14, 2016 j ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativKaram et al., 2013). Most well-studied is the role of NMD
in the neural cell lineage. Studies in Drosophila mela-
nogaster, zebrafish, and mammalian cell lines have shown
that NMD is critical for specific steps in neural develop-
ment (Jolly et al., 2013; Lou et al., 2014; Metzstein and
Krasnow, 2006; Wittkopp et al., 2009). In humans, muta-
tions in the NMD gene, UPF3B, lead to intellectual
disability (Nguyen et al., 2014). These cognitive disorders
are likely to result from developmental defects; indeed pa-
tients with mutations in UPF3B and copy-number variants
of other NMD genes commonly have neurodevelopmental
disorders, including schizophrenia and autism (Nguyen
et al., 2014). Less is known about the influence of NMD
on non-neuronal cell lineages. Loss of the NMD factor
UPF2disrupts hematopoiesis and liver development in vivo
(Thoren et al., 2010; Weischenfeldt et al., 2008), and evi-
dence suggests that NMD cooperates with another RNA
decay pathway to influence muscle cell differentiation
(Gong et al., 2009). While these studies strongly suggest
that NMD has roles in various developmental systems,
the underlying mechanism is poorly understood.
Here we examine the role of NMD in the differentiation
of human embryonic stem cells (hESCs). This was moti-
vated by earlier work suggesting that NMD functions
in early embryogenesis: null mutations in four NMD
genes—Upf1, Upf2, Smg1, and Smg6—result in early embry-
onic lethality in mice (Li et al., 2015; McIlwain et al., 2010;
Medghalchi et al., 2001; Weischenfeldt et al., 2008). These
studies raised the possibility that NMD is critical for very
early embryonic developmental events inmammals, a pos-
sibility we investigate in hESCs. Our studies reveal a role for
NMD in definitive endoderm and mesoderm lineagers.
ecommons.org/licenses/by-nc-nd/4.0/).
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segregation through the ability of NMD to regulate the
levels of mRNAs encoding signaling pathway factors.RESULTS
NMD Regulation in Stem and Differentiated Cells
We previously reported that mouse neural stem cells have a
high magnitude of NMD and that this must be downregu-
lated to permit neural differentiation (Lou et al., 2014). To
explorewhether this is a general property ofNMD,we inves-
tigated other differentiation systems, with a focus on hu-
man development. We identified three scenarios in which
NMD-factor genes were downregulated: (1) human neural
progenitor cell differentiation, (2) human epidermal kerati-
nocyte differentiation, and (3) human pancreatic progeni-
tor cells differentiated into b-islet cells in vivo (Figure S1A).
As evidence that the downregulation of these NMD factors
is functionally relevant, the well-established NMD direct
target transcripts, GADD45B and ATF3 (Chan et al., 2007;
Mendell et al., 2004), were upregulated, indicative of
decreased NMD activity during differentiation (Figure S1A).
To further test whether NMDdownregulation is a general
property associated with differentiation, we mined an
RNA-seq database from 452 human pluripotent and 254
non-pluripotent cell lines and found that three NMD
factors are highly significantly (p < 2.5 3 10123) downre-Figure 1. NMD Downregulation Promotes hESC Endoderm Differen
(A) qPCR analysis of the indicated NMD-factor mRNAs in H9 hESCs dif
specific markers. All transcript levels were normalized to the level of
independent experiments).
(B) NMD activity in H9 hESCs differentiated into the three primary ger
mRNA (determined by qPCR analysis) expressed from transiently trans
indicated in (A) (n = 3 independent experiments).
(C) Cell-cycle analysis of undifferentiated and differentiated hESCs d
entiation’’ conditions or differentiated into the specific lineages ind
depleted of UPF1, see Figure S1F). Error bars represent SD. *p < 0.05
(D) qPCR analysis of transcripts encoding cell cycle factors in hESCs dep
with the siLUC negative control small interfering RNA (siRNA); siUPF1
cultured under ‘‘non-differentiation’’ conditions. Statistical analysis w
(E) The effect of sustained NMD on endoderm differentiation. qPCR an
and incubated with activin or diluent alone. Statistical analysis was p
not detectable.
(F) The effect of NMD perturbation on endoderm differentiation. Left: q
H9 cells. Right: qPCR analysis of H9 cells depleted of UPF3B (shUPF3
treated H9 Tet-shUPF3B cell clone) (see Figure S1F). Cells were incuba
as indicated in (A) (n = 3 independent experiments).
(G) FACS analysis of UPF1 protein expression and lineage-specific
Ctrl, H9 hESCs; UPF1 KD, the A6-shUPF1 H9 cell clone (panel C). The
or differentiated down the lineages shown using the 4-day prot
experiments).
(H) FACS analysis of UPF1 protein expression and the endoderm ma
‘‘non-differentiation’’ conditions or for 2 days of the 4-day definitive
experiments).
846 Stem Cell Reports j Vol. 6 j 844–857 j June 14, 2016gulated in non-pluripotent human cell lines relative to
pluripotent human cell lines (Figure S1B). Because this rep-
resents a very large number of cell lines, we regard this as
strong evidence that NMD factors are highly expressed in
human pluripotent stem cells and that their level decreases
upon loss of pluripotency.
We next investigated NMD regulation during early differ-
entiation using hESCs and found that culturing H9 hESCs
under conditions that favor their differentiation into
definitive endoderm led to reduced expression of most
NMD-factor genes (Figure 1A). In contrast, directed differen-
tiation toward ectoderm and mesoderm led to significantly
increased expression of several NMD-factor genes (Fig-
ure 1A). To determine whether the divergent expression of
NMD-factor genes during thedifferentiationof the threepri-
mary germ layers is a peculiarity of the H9 hESC line, we
examined the Hue6 and Cyt49 hESC lines and observed
similar results (Figure S1C). As evidence for conservation,
we found that the pluripotentmouse P19 cell line displayed
similarly divergent regulation when differentiated into the
three primary germ layers (Figure S1D).
In agreement with the analysis described above, immu-
nofluorescence showed that UPF1 protein expression was
significantly reduced in the endoderm lineage compared
with undifferentiatedH9 cells (Figure S1E), whileUPF1 pro-
tein levels were relatively higher in mesoderm- and ecto-
derm-differentiated H9 cells (data not shown). As evidencetiation
ferentiated into the three germ-layer cells. Bottom panel: lineage-
L19 RNA. Error bars depict SEM. *p < 0.05 (Student’s t test; n = 3
m-layer cells. NMD activity is reflected by the ratio of PTC+ and PTC
fected NMD reporter plasmids. Statistical analysis was performed as
epleted of NMD factors. The cells were cultured under ‘‘non-differ-
icated. Ctrl, H9 hESCs; UPF1 KD, A6-shUPF1 H9 cell clone (stably
(Student’s t test; n = 3 independent experiments).
leted of the NMD factor UPF1. siLUC, H9 cells transiently transfected
, H9 cells transiently transfected with a UPF1 siRNA. All cells were
as performed as indicated in (A) (n = 3 independent experiments).
alysis of H9 hESCs transfected with the indicated expression vectors
erformed as indicated in (A) (n = 3 independent experiments). ND,
PCR analysis of the A6-shUPF1 H9 cell clone (panel C) versus control
B; DOX-treated Tet-shUPF3B cell clone) versus control cells (EtOH-
ted with activin or diluent alone. Statistical analysis was performed
markers in hESCs differentiated into the indicated cell lineages.
cells were cultured either under ‘‘non-differentiation’’ conditions
ocol described in Experimental Procedures (n = 3 independent
rker, SOX17, in the hESCs described in (G) cultured either under
endoderm differentiation protocol used in (G) (n = 3 independent
for the functional significance of modulation of the NMD
factors, a luciferase-based NMD reporter demonstrated
that hESCs cultured under conditions that favor endoderm
differentiation had strongly reduced NMD activity, while
hESCs cultured under conditions that favored mesoderm
or ectoderm differentiation had increased NMD activity
(Figure 1B). We conclude that the differentiation of human
pluripotent cells tends to be accompanied by reduced
magnitude of NMD, but differentiation of hESCs into
the primary germ layers leads to divergent regulation of
NMD, with dramatic NMD downregulation exhibited by
endoderm, and increased NMD magnitude exhibited by
mesoderm and ectoderm.
NMD Promotes hESC Proliferation
We next considered whether the regulation of NMD activ-
ity during hESC differentiation was linked with cellular
proliferation. We previously showed that NMD stimulates
neural cell proliferation by promoting progression through
the G1/S phase of the cell cycle (Lou et al., 2014).We exam-
ined whether this G1/S transition-promoting activity ex-
tends to the primary germ layers. In support of this hypoth-
esis, we found that hESCs cultured under conditions that
favor ectoderm differentiation had both a high level of
NMD activity (Figure 1B) and a high S/G1 ratio (Figure 1C),
indicative of high proliferative activity (Kapinas et al.,
2013). In contrast, hESCs cultured to generate endoderm
had low NMD activity (Figure 1B) and low S/G1 ratio (Fig-
ure 1C), while hESCs cultured to formmesodermhad inter-
mediate levels of both (Figures 1B and 1C). We conclude
that there is a correlation between the extent of the S phase
of the cell cycle and NMD activity.
To determine whether NMD has a causal role in the cell
cycle of hESC-derivative lineages, we examined the effect
of NMD perturbation. Consistent with our previous results
in mouse neural stem cells (Lou et al., 2014), we found that
knockdown of UPF1 or UPF3B (Figure S1F) in hESCs
cultured to form mesoderm or ectoderm led to accumula-
tion in G1 (Figures 1C and S1G). In contrast, cells differen-
tiated toward endoderm exhibited little or no cell-cycle
shift in response to NMD-factor knockdown, consistent
with the fact that these cells already have lowNMDmagni-
tude (Figure 1B). In support of NMD stimulating G1-to-S
progression by destabilizing mRNAs encoding G1/S inhibi-
tors, we found that the mRNAs encoding several cell-cycle
inhibitors were upregulated in UPF1-depleted hESCs (Fig-
ure 1D), two of which were also upregulated by depletion
of UPF3B (Figure S1H). To investigate whether NMD acts
to promote proliferation by promoting ‘‘stemness,’’ we
examined mRNAs encoding pro-stem factors. UPF1-
depleted hESCs had only modestly reduced levels of pro-
stem factor mRNAs (Figure 1D), while UPF3B-depleted cells
did not have significantly altered levels of these mRNAs(Figure S1H), suggesting that NMD is unlikely to act by pro-
moting the stem-like state of hESCs. We conclude that
NMD stimulates the proliferation of hESC-derivative cells
primarily by promoting the G1-to-S cell-cycle transition.
TheNMDDownregulatory Response Drives Endoderm
Differentiation
As demonstrated above, NMD factor downregulation is a
general property of many differentiation systems (Figures
1A, S1A, and S1B). To determine whether this phenome-
non has a functional role, we elected to focus most of our
remaining studies on endoderm differentiation, which is
accompanied by strong NMD repression (Figure 1B). As
one approach, we force-expressed a sufficient level of
NMD factors to prevent their downregulation to determine
whether this inhibited endoderm-directed differentiation
and maintained stem cell markers, as predicted if NMD
downregulation is required for this differentiation event.
We found that maintenance of UPF1 expression in this
manner inhibited the upregulation of the endoderm
marker, SOX17, and largely maintained expression of the
stem cell marker, OCT4 (Figure 1E, left). Forced expression
of modest levels of UPF3B led to similar results (Figure 1E,
right). Forced expression of either UPF1 or UPF3B also
inhibited SOX17 expression in hESCs differentiated into
embryoid bodies (data not shown). While maintenance
of neither UPF3B nor UPF1 expression was sufficient to
completely suppress endoderm differentiation, we note
that, in these experiments, we manipulated the level of
only one of the many NMD factors downregulated
during endoderm differentiation (Figure 1A, top; Figures
S1C and D).
To determine whether NMD downregulation is sufficient
to elicit the endoderm program in hESCs grown under
‘‘non-differentiation’’ conditions, we performed loss-of-
function experiments. We found that depletion of UPF1
was sufficient to increase SOX17 expression in hESCs under
these conditions (Figure 1F, left). While this induction was
much less than elicited by the potent endoderm differenti-
ation inducer, activin, it was still >10-fold, indicating that
UPF1 depletion is sufficient to trigger at least the initial
stages of the endoderm program. As further evidence for
this, another endoderm marker, CXCR4, exhibited the
same pattern of expression. Two additional lines of evi-
dence supported the notion that NMD downregulation
promotes endoderm differentiation. First, depletion of
UPF1 in combination with activin treatment elicited
higher SOX17 expression than activin treatment alone
(Figure 1F, left). Second, depletion of another NMD factor,
UPF3B, caused virtually the same effects as UPF1 depletion
(Figure 1F, right).
As a final test of the role of NMD downregulation
in endoderm differentiation, we examined the effect ofStem Cell Reports j Vol. 6 j 844–857 j June 14, 2016 847
NMD-factor knockdown on hESCs grown under pro-endo-
derm differentiation conditions. Using fluorescence-acti-
vated cell sorting (FACS) analysis, we found that depletion
of UPF1 coupled with activin treatment for 4 days led to a
dramatically increased SOX17 protein level in most hESCs
relative to cells treated with activin alone (Figure 1G).
Furthermore, UPF1 depletion coupledwith activin induced
SOX17 protein expression after only 2 days of activin cul-
ture; whereas activin treatment alone did not significantly
induce SOX17 protein expression at this early time point
(Figure 1H). Together, these gain- and loss-of-function ex-
periments provided strong evidence that NMD downregu-
lation is a key driver of the endoderm differentiation
program.
Identification of NMD Substrates in hESCs
To understand the underlying mechanism by which NMD
influences hESC differentiation, it is critical to define
NMD-regulated transcripts. To this end, we performed
RNA-seq analysis on hESCs depleted of UPF1 and control
hESCs. We found that 90% depletion of UPF1 resulted
in significant dysregulation of 1,497 genes (Figure 2A and
Table S1). As evidence that a large proportion of genes upre-
gulated by UPF1 depletion encode direct target transcripts,
we found that 3.5 times more genes were upregulated
(1,163) than downregulated (334) (q < 0.05; >1.5-fold
change) (Figure 2A andTable S1). In addition,we assembled
a list of ‘‘core NMD substrates,’’ defined by high phospho-
UPF1 occupancy and other assays in previous studies. The
majority of these RNAs (28 of 34 examined) were upregu-
lated in UPF1-depleted hESCs (Figure 2B), validating our
RNA-seq analysis and providing strong evidence that
NMD is disrupted in UPF1-depleted hESCs.
To compile a list of direct NMD targets in hESCs, we first
generated a database of high-confidence NMD substrates
previously identified in the literature. To qualify as an
NMD target, the RNA must have been shown to be an
NMD substrate on the basis of more than one assay (e.g.,
upregulation and/or stabilization in response to NMD-fac-
tor depletion or high UPF1 or phospho-UPF1 occupancy).
We found that 200 of these high-confidence NMD sub-
strate genes were upregulated in UPF1-depleted hESCs (Fig-
ure S2A and Table S5). As another means to identify direct
NMD targets in hESCs, we performed RNA-seq half-life
analysis on UPF1-depleted and control hESCs treated
with the transcriptional inhibitor actinomycin D. This
identified RNAs from 389 genes that were stabilized by
depletion of UPF1, all of which are therefore strong candi-
dates to be direct NMD targets (Table S3 and Figure S2B). A
large percentage (30%) of the genes corresponding to
RNAs stabilized by depletion of UPF1 overlapped with pre-
viously defined high-confidence NMD substrate genes (Fig-
ure 2C and Table S5).848 Stem Cell Reports j Vol. 6 j 844–857 j June 14, 2016Several features in mRNAs that are responsible for trig-
gering decay by NMD have been defined. Two features
that elicit NMD in some circumstances are an exon-exon
junction downstream of the stop codon defining the
main open reading frame and a long 30 UTR (Lykke-Ander-
sen and Jensen, 2015).Whenwe compared RNA transcripts
upregulated versus unaltered byUPF1 depletion, we did not
observe a statistical difference in either downstream exon
junction (dEJ) frequency or 30 UTR length (Figure S2C and
Table S2). Likewise, the RNAs stabilized by UPF1 depletion
did not have a shift in these two parameters compared
with unchanged RNAs (Figure S2C and Table S4). While
there was a statistical difference in both parameters be-
tween upregulated and downregulated transcripts, this
was not observed between stabilized and destabilized tran-
scripts (Figure S2C).Weconclude thatneither 30UTR length
nor dEJ content is sufficiently enriched in RNAs expressed
in NMD-depleted hESCs to be detected at the genome-
wide level, probably due to indirect effects of UPF1 deple-
tion. These findings are also consistent with the emerging
evidence that context determines whether or not an
‘‘NMD-inducing feature’’ elicits RNA decay (Fatscher et al.,
2015; Huang and Wilkinson, 2012; Zetoune et al., 2008).
NMD Targets Signaling Pathway mRNAs in hESCs
Gene ontology (GO) analysis revealed that mRNAs stabi-
lized or upregulated byUPF1 depletion correspond to genes
enriched inmany functional categories (Figure 2D). Several
subcategories of ‘‘differentiation’’ and ‘‘development’’ were
significantly enriched (colored in purple in Figure 2D),
including components of the nuclear factor kB signaling
pathway (Figures 2DandS2D),whichpromptedus to inves-
tigate other signaling pathways, including those critical for
hESCdifferentiation (Sui et al., 2013).Manual inspection of
our RNA-seq datasets revealed that UPF1 depletion altered
the expression of genes involved in several major signaling
cascades (Figures 2E and S2D).We used qPCR to verify regu-
lation by UPF1 in a subset of these signaling genes (Fig-
ure 3A). Many of the mRNAs encoded by these genes
appeared to be direct NMD substrates, as they were also sta-
bilized in UPF1-depleted hESCs (Figure S3 and Table S6).
The known actions of many of these signaling pathways
raised the possibility that one or more of them act down-
stream of NMD to repress definitive endoderm differentia-
tion. For example, we hypothesized that the transforming
growth factor b (TGF-b) and fibroblast growth factor (FGF)
pathways are inhibited by NMD, as both of these signaling
mechanisms are known to promote definitive endoderm
differentiation (Loh et al., 2014; Sui et al., 2013; Wang
and Chen, 2015). Consistent with this hypothesis, we
found that the majority of positive TGF-b signaling
factors were negatively regulated by UPF1 (Figure 2E).
Conversely, most negative regulators of TGF-b signaling
Figure 2. Genome-wide Analysis of UPF1-Regulated Transcripts in hESCs
(A) Gene expression of UPF1-depleted hESCs compared with control hESCs. UPF1 was depleted by transfecting UPF1 siRNA (20 nM) in H9
cells (siUPF1 1 and siUPF1 2) as described in Figure 1D; cells transiently transfected with a siRNA against Luciferase (siLuc 1 and siLuc 2)
serve as the negative control. q < 0.05; >1.5-fold differentially expressed (n = 2 independent experiments).
(B) NMD substrates are upregulated in UPF1-depleted hESCs. RNA-seq analysis, described in (A), of 28 ‘‘core NMD substrates’’ (previously
identified NMD substrates enriched for phospho-UPF1 binding) (Kurosaki et al., 2014 and Lynne Maquat, personal communication) and six
transcripts previously identified as NMD substrates in at least two literature sources (Table S5).
(C) Overlap of genes encoding mRNAs stabilized by UPF1 depletion with genes encoding NMD targets identified by previous papers.
References can be found in Supplemental Experimental Procedures.
(D) GO analysis of functional categories overrepresented (p < 0.01) among genes significantly upregulated or significantly stabilized in
hESCs depleted of UPF1. Development/differentiation-related and signaling categories are highlighted in purple.
(E) Transcripts encoding signaling proteins dysregulated in UPF1-depleted hESCs. RNA-seq analysis is described in (A).
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were upregulated by UPF1. As evidence that NMD acts
through FGF signaling, we found that most positive FGF
signaling genes were negatively regulated by UPF1 (Fig-
ure 2E). We next examined two signaling pathways that
are known to inhibit definitive endoderm differentiation:
the WNT and NOTCH pathways (Loh et al., 2014; Ogaki
et al., 2013; Sui et al., 2013; Wang and Chen, 2015). These
pathways would be predicted to be stimulated by NMD,
since NMD inhibits endoderm differentiation. Consistent
with this, we found that most of the WNT and NOTCH
pathway genes exhibiting consistently altered expression
were positively regulated by UPF1 (Figure 2E). Finally, we
examined the HIPPO pathway, as it is also known to influ-
ence definitive endoderm differentiation (Estara´s et al.,
2015), but we did not observe a clear trend in UPF1-medi-
ated regulation (Figure S2D).
Because of the large body of literature demonstrating that
theWNTand TGF-b pathways direct and regulate definitive
endoderm differentiation (Loh et al., 2014; Sui et al., 2013;
Wang and Chen, 2015), we performed follow-up experi-
ments to examine more directly whether NMD acts
through these two pathways to influence endoderm differ-
entiation. As further support that NMD augments WNT
signaling, qPCR analysis verified that most positive regula-
tors of the canonicalWNTpathwaywere downregulated by
UPF1 depletion (Figure 3A). This notion was further sup-
ported by the finding from RNA-seq analysis that negative
regulators of canonical WNT signaling were upregulated
by UPF1 depletion (Figure 2E). As direct evidence that
NMD promotes canonical WNT signaling, we found that
UPF1-depleted hESCs had reduced upregulation of canon-
ical WNT target genes in response to treatment with
WNT3A ligand (Figure 3B). Conversely, UPF1 overexpres-
sion increased canonical WNT target gene expression
(Figure 3B). These data, coupled with the well-established
ability of WNT signaling to inhibit endoderm differentia-
tion (Loh et al., 2014; Sui et al., 2013; Wang and Chen,
2015), support amodel in which NMD represses endoderm
differentiation by promoting WNT signaling.
We next performed further analysis to confirm whether
NMD represses TGF-b signaling. As described above, RNA-
seq analysis demonstrated that positive regulators of this
pathway were generally increased in expression following
UPF1 depletion, while most negative regulators exhibited
decreased expression (Figure 2E), a finding we confirmed
by qPCR analysis (Figure 3A). As direct evidence that
UPF1 represses TGF-b signaling in hESCs, we found that
UPF1-depleted hESCs had elevated levels of SMAD2 and
SMAD3 protein, as well as phosphorylated SMAD2 and
SMAD3 (Figure 3C). Together, these data support a model
in which NMD downregulation drives endoderm differen-
tiation by stimulating TGF-b signaling and repressingWNT
signaling (Figure 3D).850 Stem Cell Reports j Vol. 6 j 844–857 j June 14, 2016Because it is well established that the ligands stimulating
TGF-b signaling in vivo often operate in a dose-dependent
manner to influence developmental fate (Guo and Wang,
2009; Mehlen et al., 2005), we analyzed the dose-depen-
dent effects of the TGF-b ligand, activin. We found that
modest overexpression of UPF1 was sufficient to dampen
the upregulation of the TGF-b-signaling component genes,
MIXL1 and SOX17, in response to a range of activin con-
centrations (Figure 4A). Similar results were obtained in
response to forced expression of modest levels of the
NMD factor UPF3B (Figure 4B), providing strong evidence
that NMD itself confers repression of this pathway. We
also tested the converse—the effect of repressed UPF1 on
TGF-b signaling—and found a dose-dependent increase
in TGF-b signaling (Figures 4C and D). Intriguingly, a
threshold was observed in which suppressed UPF1
enhanced TGF-b signaling in response to high doses, but
not low doses, of activin (Figure 4C). This supports the pos-
sibility that NMD regulation specifically influences TGF-
b-signaling-induced events when cells are bathed in high
concentrations of activin, such as when they are near the
source cells that generate this morphogen.
NMD Modulates the Balance of Two Morphogenetic
Signals Driving hESC Differentiation
A delicate balance of bone morphogenetic protein (BMP)
and TGF-b signaling dictates hESC lineage specification
toward endoderm or mesoderm. Both BMP and TGF-b
signaling drive formation of mesendoderm, an intermedi-
ate lineage between hESCs and definitive endoderm and
mesoderm (Loh et al., 2014). After mesendoderm forma-
tion, TGF-b signaling triggers endoderm differentiation,
while BMP signaling elicits mesoderm differentiation
(Guo and Wang, 2009; Wang and Chen, 2015). If NMD
were to serve as a switch between these lineages, it would
need to differentially regulate TGF-b and BMP signaling.
To test this hypothesis, we examined the effect of NMD
manipulation on the response of hESCs to BMP4. We
found that UPF1 overexpression enhanced BMP signaling,
as measured using the BMP pathway target genes Brachyury
andHand1 (Figure 5A), while UPF1 depletion reduced BMP
signaling (Figure 5B). Coupled with our finding that NMD
inhibits TGF-b signaling (Figures 2 and 3), this supports
the notion that NMD inversely regulates the TGF-b and
BMP signaling pathways and thereby is a good candidate
to influence endoderm versus mesoderm cell fate.
Because definitive endoderm formation is most effi-
ciently initiated by a combination of TGF-b and BMP
signaling (Guo and Wang, 2009), we tested whether
NMD influences endoderm differentiation when both of
these pathways are activated simultaneously. In control
hESCs, endoderm differentiation was elicited by activin
alone but not BMP4 alone (Figures 5C, S4A, and S4B),
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(A) Forced maintenance of UPF1 expression
represses TGF-b signaling and endoderm
differentiation. qPCR analysis of H9 hESCs
transiently transfected with a UPF1 expres-
sion vector or empty vector and differenti-
ated into the endoderm lineage with
different doses of activin (0, 25, 50, and
100 ng/ml). Statistical analysis was per-
formed as in Figure 1A (n = 3 independent
experiments).
(B) Forced maintenance of UPF3B expres-
sion represses TGF-b signaling and endo-
derm differentiation. The experiment was
performed analogous to (A) except with a
UPF3B expression vector instead of a UPF1
expression vector. Statistical analysis was
performed as in Figure 1A (n = 3 indepen-
dent experiments).
(C) UPF1 depletion stimulates activin-
induced TGF-b signaling and endoderm
differentiation. qPCR analysis of the A6-
shUPF1 clone (Figure 1C) or control hESCs
differentiated into the endoderm lineage
with different doses of activin. Statistical
analysis was performed as in Figure 1A (n = 3
independent experiments).
(D) Dose-dependent effect of UPF1 on TGF-b
signaling and endoderm differentiation.
qPCR analysis of H9 cells transfected with
different doses of LUC or UPF1 small hairpin
RNA (shRNA) expression vectors and then
incubated for 3 days with 100 ng/ml activin.
Statistical analysis was performed as in
Figure 1A (n = 3 independent experiments).confirming previous studies (Loh et al., 2014). Also vali-
dating published findings (Teo et al., 2012), we found
that optimal endoderm differentiation was triggered by ac-
tivin and a low concentration of BMP4 (Figures 5C, S4A,
and S4B). To test the role of NMD in this process, we
depleted UPF1 and found that this triggered increased
SOX17 and CXCR4 expression in response tomost concen-(B) NMD modulates the WNT signaling pathway. qPCR analysis of mRN
hESCs transfected with the vectors described in Figure 1 for 48 hr, and
siUPF1 depleted UPF1 levels by 90% ± 4% and UPF1 overexpression in
was performed as in Figure 1A (n = 3 independent experiments).
(C) UPF1 inhibits TGF-b signaling in hESCs. Western blot analysis of th
right panel shows the mean of protein quantification; values were norm
*p < 0.05 (n = 3 independent experiments).
(D) Model: NMD magnitude shifts cell signaling competence. Two cells
milieu of signaling ligands.
852 Stem Cell Reports j Vol. 6 j 844–857 j June 14, 2016trations of activin and BMP4 (Figures 5C and S4A). Similar
results were observed in response to depletion of the NMD
factor UPF3B (Figure S4B). Together, these data demon-
strate that NMD downregulation is critical for endoderm
differentiation, not only under suboptimal conditions
(e.g., activin alone) but also under optimal (activin and
BMP signaling) conditions.As encoding the WNT downstream targets, CCND1 and NR0B1, in H9
then incubated with WNT3A (100 ng/ml) for 24 hr. Treatment with
creased UPF1 levels by 2.1 ± 0.2 fold (Table S6). Statistical analysis
e A6-shUPF1 H9 cell clone (Figure. 1C) and H9 cells as a control. The
alized to b-ACTIN as the internal control. Error bars represent SEM.
with different levels of NMD activity respond differently to the same
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Figure 5. Evidence that UPF1 Influences
Mesoderm vs. Primitive Endoderm Fate
(A) UPF1 upregulates BMP signaling and
mesoderm differentiation markers. qPCR
analysis of H9 cells transiently transfected
with a UPF1 expression vector or empty
expression vector (Ctrl) and cultured for
3 days in mesoderm induction medium.
Statistical analysis was performed as in
Figure 1A (n = 3 independent experiments).
(B) UPF1 downregulation inhibits BMP
signaling and mesoderm differentiation
markers. qPCR analysis of H9 cells tran-
siently transfected with a UPF1 shRNA or
LUC shRNA (control) expression vector. Cell-
culture conditions and statistical analysis
are as described in (A) (n = 3 independent
experiments).
(C) UPF1 downregulation stimulates endo-
derm differentiation markers. qPCR analysis
of the endoderm marker, SOX17, performed
on the A6-shUPF1 clone (UPF1 KD)
and control (Ctrl) H9 hESCs described in
Figure 1C. The cells were differentiated into the mesendoderm lineage (for 1 day) and then incubated for 3 days with different
concentrations of BMP4 (0, 5, 10, and 50 ng/ml) and activin (0, 25, 50, and 100 ng/ml). Statistical analysis was performed as in Figure 1A
(n = 3 independent experiments).
(D) UPF1 downregulation inhibits BMP signaling and mesoderm differentiation markers. qPCR analysis of the mesoderm marker,
BRACHYURY, performed on A6-shUPF1 clone and control cells described in (C). Statistical analysis was performed as in Figure 1A (n = 3
independent experiments).We next tested the role of NMD in hESCs grown under
mesoderm differentiation conditions. As previously demon-
strated (Wang and Chen, 2015), we found that BMP4 alone
elicited mesoderm differentiation, whereas activin alone
did not, as measured using the mesoderm marker gene,
Brachyury (Figures 5D and S4C). In striking contrast to what
we observed for endoderm differentiation, depletion of the
NMD factor, UPF1, caused decreased Brachyury expression
in response to most concentrations of BMP4 and activin
(Figure 5D). Similar results were observed in response to
depletionof theNMDfactor,UPF3B (FigureS4C), reinforcing
our hypothesis that NMD serves to stimulate mesoderm
induction. As further evidence that NMD influences
mesoderm versus endoderm fate, we found that NMD
perturbation (by UPF1 or UPF3B depletion) eliminated the
repression of endoderm differentiation caused by high
BMP4 concentrations (Figures 5C, S4A, and S4B). Together,
these data provide strong evidence that NMD acts through
well-established signaling pathways to control hESC fate.DISCUSSION
In this study, we provide several lines of evidence that
the highly conserved RNA degradation pathway, NMD,strongly influences hESC differentiation. Through marker
analysis, we found that NMD promotes the differentiation
of hESCs into mesoderm and inhibits their differentiation
into definitive endoderm (Figures 1E–1H, 3, 4, and 5).
Our results suggest that NMD magnitude is critical for
dictating the proportion of cells that progress down these
two cell lineages by regulating the balance between TGF-
b and BMP signaling (Figure 6). We obtained several lines
of evidence that NMD inhibits TGF-b signaling and acti-
vates BMP signaling (Figures 3, 4, 5, S3, and S4), which
are known to promote endoderm and mesoderm
differentiation, respectively (Loh et al., 2014). Thus, by
altering NMD magnitude, the relative strength of these
two signaling pathways is shifted, thereby influencing
cell fate (Figure 6). Recent studies have identified an
array of modulatory factors that shift NMD magnitude,
including microRNAs, eIF2a phosphorylation, RNA-bind-
ing proteins, and the level of specific NMD factors (Ge
et al., 2016; Huang and Wilkinson, 2012; Karam et al.,
2013; Shum et al., 2016). We suggest that one or more of
these mechanisms may be responsible for altering the
magnitude of NMD in hESCs to influence cell fate.
We obtained some evidence that NMD not only influ-
ences hESC fate through TGF-b and BMP signaling, but
also through the WNT, FGF, and NOTCH pathwaysStem Cell Reports j Vol. 6 j 844–857 j June 14, 2016 853
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Figure 6. Model
Endoderm versus mesoderm fate is dictated by NMD through
regulation of TGF-b and BMP signaling.(Figure 2E). This raises the possibility that the ability of
NMD to influence endoderm and mesoderm differentia-
tion is a combinatorial process amplified by its ability to
act through several signaling pathways. As a further level
of complication, NMD may act at several differentiation
steps. The differentiation of definitive endoderm and
mesoderm from hESCs requires an initial commitment to
the mesendodermal cell lineage (Sui et al., 2013). Commit-
ment to this intermediate cell fate is promoted by FGF,
WNT, BMP, and TGF-b signaling (Loh et al., 2014). After
hESCs reach the mesendoderm stage, their subsequent
development intomesoderm or endoderm further depends
on the local signalingmilieu. TGF-b and FGF signaling pro-
mote differentiation into definitive endoderm, while BMP
and WNT signaling elicit differentiation into mesoderm
(Loh et al., 2014). Given our evidence that NMD influences
all these signaling pathways, it would not be surprising if
NMD magnitude affects several of these differentiation
steps, including the initial generation of mesendoderm.
We note that while some definitive endoderm markers
regulated by NMD (MIXL1 and EOMES) are also expressed
by mesendoderm, other markers regulated by NMD are
considered specific for definitive endoderm or mesoderm
(SOX17/CXCR4 and BRACHYURY/HAND1, respectively)
(Izumi et al., 2007).
NMDmay act in two non-mutually exclusive ways to in-
fluence hESC cell fate. First, NMD may serve as a switch
that cooperates with transcriptional mechanisms to drive
hESC differentiation. This follows from the fact that simul-
taneous transcriptional activation and mRNA stabilization
elicit more dramatic increases in steady-state mRNA level
than either of these processes alone. For example, our re-
sults suggest that activin-triggered transcriptional induc-
tion coupled with NMD suppression would increase not
only the synthesis but also the stability ofmRNAs encoding
pro-endoderm differentiation proteins, thereby driving
robust endoderm differentiation. Second, NMD may rein-854 Stem Cell Reports j Vol. 6 j 844–857 j June 14, 2016force cell-fate decisions in the face of genetic or environ-
mental perturbation. This follows from our finding that
extracellular signals triggering a given cell fate alter the
magnitude of NMD to reinforce that particular cell fate.
For example, we found that activin treatment suppresses
NMD magnitude (Figure 1B) which, in turn, leads to upre-
gulation ofmRNAs encoding pro-TGF-b factors (Figure 3A).
This would further stimulate TGF-b signaling and strongly
drive endoderm differentiation. Our results suggest that a
similar feedback mechanism involving the WNT signaling
pathwaymay exist (Figure 6). Finally, our results imply that
NMD allows for subtle responses to morphogen gradients.
For example, NMD specifically modulates hESC fate in
response to high activin doses but not low activin doses
(Figure 4). If confirmed in vivo, this indicates an extra layer
of developmental control whereby the magnitude of NMD
can trigger different cell fates that depend on the local
morphogen milieu.
Our finding that NMD has inverse effects on hESC
endoderm and mesoderm differentiation differs from
what was recently reported for mouse ESCs (mESCs). Li
et al. (2015) found that loss or depletion of NMD factors
in mESC blocks their differentiation into all three primary
germ layers. Because these authors depleted several
different NMD factors, including UPF1, which we also
depleted, we regard it as unlikely that the different find-
ings of our two studies are due to NMD branch-specific ef-
fects or non-NMD functions of NMD factors. Instead, a
more likely explanation is that mESCs and hESCs differ
with regard to their responses to NMD. This may stem
from the fact that mESCs and hESCs exhibit intrinsic spe-
cies-specific differences in factor requirements and expres-
sion patterns (Blair et al., 2011; Moon et al., 2006). In
addition, recent studies have identified differences in line-
age-specific markers originally thought to be conserved
between mouse and human (Blakeley et al., 2015), as
well as differences between mESC and hESC differentia-
tion programs (Moon et al., 2006). As an example of
the latter, while both the FGF and WNT pathways govern
primate primitive endoderm versus epiblast cell fate,
only FGF acts in the equivalent pathway in rodents (Bor-
oviak et al., 2015). Our evidence that NMD regulates
both WNT and FGF signaling (Figures 2E, 3A, and 3B)
may partly explain NMD’s differential effects on hESCs
and mESCs. These studies highlight the need to perform
research on human pluripotent cells, which often behave
differently from mouse pluripotent cells.
Using both standard RNA-seq and RNA-seq half-life anal-
ysis, we identified UPF1-regulated transcripts that are good
candidates to be direct NMD targets in hESCs. There was
considerable overlap between these candidate NMD target
transcripts expressed in hESCs with previously identified
high-confidence NMD substrates (Figures 2C and S2A;
Table S5). We regarded this overlap as remarkable, given
that few high-confidence NMD substrates have thus far
been defined in the field and most have been identified
in cell lines that bear little resemblance to hESCs (e.g.,
HeLa and HEK). The overlap was particularly surprising
given that NMD has been shown to exhibit tissue speci-
ficity (Huang et al., 2011; Karam et al., 2013). We suggest
that the high-confidence NMD substrate database we
compiled (Figure 2B and Table S5) is a valuable resource
for the field.
The mRNAs identified as significantly upregulated or
significantly stabilized upon UPF1 depletion in hESCs
were enriched in several GO categories related to differ-
entiation and morphogenesis (Figure 2D). We note, how-
ever, that many of these putative NMD substrates require
further assays to determine whether they are bona
fide direct NMD targets. The identification of direct
NMD targets is clouded by the fact that known ‘‘NMD-
inducing features’’ do not necessarily trigger NMD. For
example, while long 30 UTRs are a well-established
NMD-inducing feature, many long 30 UTRs do not trigger
NMD (Lykke-Andersen and Jensen, 2015). Indeed, ele-
ments have been identified in long 30 UTRs that permit
NMD evasion (Toma et al., 2015), and short 30 UTRs
(<1 kb) can also trigger NMD (Eberle et al., 2008; Hogg
and Goff, 2010; Singh et al., 2008; Yepiskoposyan
et al., 2011), consistent with the recent finding that
candidate NMD substrates in mESCs have 30 UTRs with
shorter average length than control RNAs (Hurt et al.,
2013). Further empirical studies will be required before
algorithms can be created to identify high-confidence
NMD substrates in silico.
The ability of NMD to influence cell fate is not restricted
to ESCs. For example, we previously showed that high
NMD magnitude promotes epidermal cell fate and re-
presses neural cell fate (Lou et al., 2014). NMD represses
neural fate by promoting the decay of the mRNA encoding
the pro-neural differentiation factor SMAD7 (Lou et al.,
2014). How NMD stimulates epidermal cell fate is not
known. One possibility is that NMD achieves this through
its ability to stimulate BMP signaling (Figures 5 and S4C),
as epidermal differentiation requires BMP signaling (Bier
and De Robertis, 2015). Our evidence that NMD degrades
transcripts encoding a wide array of signaling factors (Fig-
ures 2E, 3A, S2B, S2D, and S3) raises the possibility that
NMD serves as a regulator of many other cell-fate decisions
during development. One subject of future investigation is
to examine the role of NMD in the differentiation of
primary germ layers at stages following those we examined
in this report. Given the diverse roles of NMD in differen-
tiation, it is not surprising that recent evidence suggests
that NMD is also involved in malignancy (Chang et al.,
2016; Liu et al., 2014; Wang et al., 2011), includingthrough altered TGF-b signaling (Chang et al., 2016).
Future studies will be required to elucidate the full com-
plement of developmental events and diseases influenced
by NMD.EXPERIMENTAL PROCEDURES
RNA and Protein Analysis
Total cellular RNA was isolated from cells and tissues using Trizol
(Invitrogen), as described by Chan et al. (2007, 2009). qPCR anal-
ysis was done in triplicate on each sample using iScript reverse
transcriptase (Bio-Rad) and a SYBR-Green PCR kit (Bio-Rad), as
described by Chan et al. (2007, 2009). Primer sequences are pro-
vided in Supplemental Experimental Procedures. Western blot
analysis was performed on protein lysates resolved in 8% and
10% SDS-PAGE gels and blotted using standard procedures, as
described byChan et al. (2007, 2009). Themembraneswere probed
with the following primary antibodies: rabbit anti-human UPF1
(from Jens Lykke-Andersen; 1:1,000 dilution), rabbit anti-human
UPF3B (from Jens Lykke-Andersen; 1:1,000 dilution), rabbit anti-
mouse SMAD2/3 (Cell Signaling, catalog #3106; 1:500 dilution),
rabbit anti-mouse phospho-SMAD2/3 (Cell Signaling, cat: #3108;
1:250 dilution), and mouse anti-b-actin (Sigma A5441; 1:2,000
dilution). The secondary antibodies used were fluorescein isothio-
cyanate- or PG-YA-conjugated anti-goat, anti-mouse or anti-rabbit
immunoglobulin G (Thermo Fisher Scientific). Quantification
was done by densitometry using Odyssey immunofluorescence
software.
Immunofluorescence and FACS Analysis
Immunofluorescence and FACS analysis were performed as con-
ventional procedures. See Supplemental Experimental Procedures
for details and antibodies used.
Cell-Cycle Analyses
Cells were trypsinized and resuspended in 0.5 ml PBS followed
by the addition of 0.5 ml of 100% ice-cold ethanol in a drop-
wise manner while vortexing. After incubation for 20 min on
ice, the cells were harvested and washed with PBS, incubated in
25 mg/ml RNase A in PBS at 37C for 30 min, and stained with
50mg/ml propidium iodide in PBS for 10min at room temperature
and analyzed by flow cytometry.
hESC Culture
All hESC culturesweremaintained at 37Cwith 5%CO2. ThehESC
lines H9, CyT49, and Hue6 (WiCell) were propagated on Matrigel
(BD Sciences)-coated six-well plates in E8medium (StemCell Tech-
nologies). See Supplemental Experimental Procedures for specific
culture conditions for in vitro differentiation into the three germ
layers.
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